The expression of 5-HT and its receptor in the intestinal mucosa of IBS patients were higher than the normal, and 5-HT receptor antagonist therapy can relieve IBS-D symptoms effectively [99,100]. This evidence concerns the gene HTR5A and irritable bowel syndrome.